Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/β-catenin signaling pathway

Molecular and Cellular Endocrinology

Volumn 314, Issue 1, 2010, Pages 70-74

  Zhang, Jin fang ^a,b   Li, Guo ^b   Chan, Chu yan ^b   Meng, Chun ling ^b   Lin, Marie Chia mi ^c   Chen, Yang chao ^b   He, Ming liang ^b   Leung, Ping chung ^b   Kung, Hsiang fu ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

BMP signaling pathway; Flavonoids of Herb Epidemium; Mesenchymal stem cells; Osteogenic differentiation; Wnt catenin signaling pathway

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CYCLIN D1; DICKKOPF 1 PROTEIN; FLAVONOID; HERBACEOUS AGENT; MESSENGER RNA; NOGGIN; WNT PROTEIN;

ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPIMEDIUM; FEMALE; GENE EXPRESSION; HERBA EPIMEDII; HUMAN; HUMAN CELL; MEDICINAL PLANT; MESENCHYMAL STEM CELL; PRIORITY JOURNAL;

EID: 70350532232     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.08.012     Document Type: Article

References (34)

1. An S.J., Li T., and Li E. Effect of kidney-tonifying herbs on ovary function and bone mass in postmenopausal women. Chin. J. Osteoporos. 6 (2000) 55-59
2. Celil A.B., and Campbell P.G. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 280 (2005) 31353-31359
3. Chen K.M., Ge B.F., Ma H.P., and Zheng R.L. The serum of rats administered flavonoid extract from Epimedium sagittatum but not the extract itself enhances the development of rat calvarial osteoblast-like cells in vitro. Pharmazie 59 (2004) 61-64
4. Day T.F., Guo X., Garrett-Beal L., and Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8 (2005) 739-750
5. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. OSf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
6. Egermann M., Goldhahn J., and Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos. Int. 16 Suppl. 2 (2005) S129-138
7. Fitzpatrick L.A. Estrogen therapy for postmenopausal osteoporosis. Arq. Bras. Endocrinol. Metab. 50 (2006) 705-719
8. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V.N., and Komm B.S. Canonical WNT signaling promotes osteogenesis by directly stimulating RUNX2 gene expression. J. Biol. Chem. 280 (2005) 33132-33140
9. Hamidouche Z., Haÿ E., Vaudin P., Charbord P., Schüle R., Marie P.J., and Fromigué O. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J. 22 (2008) 3813-3822
10. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., Deng L., Clemens T.L., and Williams B.O. Essential role of beta-catenin in post natal bone acquisition. J. Biol. Chem. 280 (2005) 21162-21168
11. Jaiswal N., Haynesworth S.E., Caplan A.I., and Burger S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64 (1997) 295-312
12. Koga H., Muneta T., Nagase T., Nimura A., Ju Y.J., Mochizuki T., and Sekiya I. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 333 (2008) 207-215
13. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblast. Cell 89 (1977) 755-764
14. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Kim H.J., and Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 278 (2003) 34387-34394
15. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., Rosen V., Stein J.L., Van Wijnen A.J., Stein G.S., Lian J.B., and Ryoo H.M. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell Biochem. 73 (1999) 114-125
16. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., and Young D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7 (2006) 1-16
17. Licata A.A. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann. Pharmacother. 39 (2005) 668-677
18. Meng F.H., Li Y.B., Xiong Z.L., Jiang Z.M., and Li F.M. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 12 (2005) 189-193
19. Meng F.H., Xiong Z.L., Jiang Z.M., and Li F.M. Osteoblastic proliferation stimulating activity of Epimedium koreanum Nakai extracts and its flavonol glycosides. Pharm. Biol. 43 (2005) 92-95
20. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J., Behringer R., and de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
21. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormonereplacement therapy: scientific review. J. Am. Med. Assoc. 288 (2002) 872-881
22. Nishio Y., Dong Y., Paris M., O_Keefe R.J., Schwarz E.M., and Drissi H. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372 (2006) 62-70
23. Pagani F., Francucci C.M., and Moro L. Markers of bone turnover: biochemical and clinical perspectives. J. Endocrinol. Invest. 28 Suppl. 10 (2005) 8-13
24. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., and Mosca J.D. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
25. Rodríguez J.P., Astudillo P., Ríos S., and Pino A.M. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr. Stem Cell Res . Ther. 3 (2008) 208-218
26. Rotella D.P. Osteoporosis: challenges and new opportunities for therapy. Curr. Opin. Drug Discov. Devel. 5 (2002) 477-486
27. Ryoo H.M., Lee M.H., and Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366 (2006) 51-57
28. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., and Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5522-5527
29. Wu H., Lien E.J., and Lien L.L. Chemical and pharmacological investigation of Epimedium species: a survey. Prog. Drug Res. 60 (2003) 51-57
30. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M., Rosen V., and Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on Osteoblastic Differentiation of Bone Marrow-Derived Stromal Cell Lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 220 (1996) 366-371
31. Yin X.X., Chen Z.Q., Liu Z.J., Ma Q.J., and Dang G.T. Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 2. Chin. Med. J. 120 (2007) 204-210
32. Zhao J.Y., Ohba S., Shinkai M., Chung U., and Nagamune T. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem. Biophys. Res. Commun. 369 (2008) 444-448
33. Zhang D.W., Cheng Y., Wang N.L., Zhang J.C., Yang M.S., and Yao X.S. Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Phytomedicine 15 (2008) 55-61
34. Zhang J.F., Li G., Meng C.L., Dong Q., Chan C.Y., He M.L., Leung P.C., Zhang Y.O., and Kung H.F. total flavonoids of Herb Epimedii improves osteogenesis and inhibits osteoclastogenesis of human mesenchymal stem cells. Phytomedicine 16 (2009) 521-529